6935.TWO
Price:
$20.5
Market Cap:
$750.40M
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. It supplies its products to Spain and Europe. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yunlin County, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2023-03-29
Stock Exchange
TWO
Ticker
6935.TWO
According to Prince Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -14.04. This represents a change of -468.25% compared to the average of 3.81 of the last 4 quarters.
The mean historical PE Ratio of Prince Pharmaceutical Co., Ltd. over the last ten years is 30.84K. The current -14.04 PE Ratio has changed -104.55% with respect to the historical average. Over the past ten years (40 quarters), 6935.TWO's PE Ratio was at its highest in in the March 2023 quarter at 184.06. The PE Ratio was at its lowest in in the March 2024 quarter at -23.82.
Average
30.84K
Median
9.26
Minimum
-207.91
Maximum
185.22K
Discovering the peaks and valleys of Prince Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 313.02%
Maximum Annual PE Ratio = 185.22K
Minimum Annual Increase = -118.92%
Minimum Annual PE Ratio = -207.91
Year | PE Ratio | Change |
---|---|---|
2024 | -14.96 | -118.92% |
2023 | 79.07 | 136.17% |
2022 | 33.48 | -116.10% |
2021 | -207.91 | 313.02% |
2020 | -50.34 | -100.03% |
The current PE Ratio of Prince Pharmaceutical Co., Ltd. (6935.TWO) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
32.53
5-year avg
-32.13
10-year avg
30.84K
Prince Pharmaceutical Co., Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prince Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prince Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Prince Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the highest PE Ratio for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the 3-year average PE Ratio for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the 5-year average PE Ratio for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
How does the current PE Ratio for Prince Pharmaceutical Co., Ltd. (6935.TWO) compare to its historical average?